Organization
First Affiliated Hospital of Zhejiang University
35 clinical trials
1 abstract
Clinical trial
A Multi-center, Prospective, Exploratory Study Evaluating the Efficacy and Safety of a Modified Si Jun Zi Tang Formula in the Perioperative Treatment of Non-small Cell Lung CancerStatus: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
Effects of Augmentation of Interpersonal Psychotherapy With High-Definition Transcranial Direct Current Stimulation for Adolescent Depression: A Randomized Clinical TrialStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Toripalimab in Combination With Cetuximab，Cisplatin and 5-FU for Conversion Therapy of Locally Nonresectable Oral Cavity Squamous Cell Carcinoma （OCSCC）Status: Recruiting, Estimated PCD: 2024-03-01
Clinical trial
A Monocenter Prospective Single Arm Study of Cladribine Plus Homoharringtonine and Cytarabine Regimen (CHA) for Induced Therapy in Adults de Novo Acute Myeloid Leukemia (Non-M3)Status: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
A Multicenter, Prospective, Randomized Controlled Clinical Study Comparing the Efficacy of VHAG and Traditional Chemotherapy Regimens in the Treatment of Adult Newly Diagnosed Early Precursor T-cell Acute Lymphoblastic Leukemia (ETP-ALL)Status: Recruiting, Estimated PCD: 2026-03-31
Clinical trial
Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets Versus Venlafaxine Hydrochloride Sustained-release Tablets in Patients With Major Depression Disorder: a Multicentre, Open-label, Parallel-group, Randomised Controlled TrialStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Research and Application of Key Technologies for Early Identification, Risk Warning and Comprehensive Intervention of Adolescent DepressionStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
A Phase 1 Study Evaluating Safety and Efficacy of C-CAR039 Treatment in Subjects With Relapsed and/or Refractory NHLStatus: Active (not recruiting), Estimated PCD: 2023-12-31
Clinical trial
Functional Cure Strategy and Clinical Study of AIDS--Study on the Reduction of HIV Viral Reservoir by Immunomodulators (IMs)Status: Recruiting, Estimated PCD: 2024-05-01
Clinical trial
Clinical Efficacy and Safety of Vortioxetine Combined With Mood Stabilizer in the Treatment of Bipolar Disorder Type II DepressionStatus: Completed, Estimated PCD: 2023-06-28
Clinical trial
A Multi-center Prospective Single Arm Clinical Study of Reduced Intensive 3 + 5 Idarubicin and Cytarabine Chemotherapy Plus Venetoclax as First-line Treatment for Adults With Acute Myeloid Leukaemia and High-risk Myelodysplastic SyndromeStatus: Not yet recruiting, Estimated PCD: 2026-04-02
Clinical trial
A Multi-center Prospective Single Arm Clinical Study of Prolonged Ultra Low-dose Decitabine Combined With Venetoclax (Bcl-2 Inhibitor) as First Line Treatment for Elderly Acute Myeloid Leukemia and High-risk Myelodysplastic SyndromesStatus: Recruiting, Estimated PCD: 2025-10-19
Clinical trial
A Multicenter, Prospective, One-arm Clinical StudyStatus: Recruiting, Estimated PCD: 2024-04-30
Clinical trial
Efficacy and Safety Study of Oral All-trans Retinoic Acid Combined With Toripalimab in Patients With Inoperable Locally Advanced, Recurrent, or Metastatic Triple-negative Breast Cancer Who Had Failed Prior Second-line or Higher Standard Therapy.Status: Not yet recruiting, Estimated PCD: 2026-04-30
Clinical trial
Immunohistochemical Study of Peripheral Blood Mononuclear Cells in Sporadic Alzheimer's Disease and Dementia With Lewy BodyStatus: Recruiting, Estimated PCD: 2023-12-01
Clinical trial
Research on the Biological Mechanism of the Efficacy of Psychotherapy for Depression Based on the Near-Infrared Functional Imaging System (fNIRS)Status: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Clinical Study on Monitoring the Plasma Concentration of Ceftazidime-Avibactam in Critically Ill PatientsStatus: Recruiting, Estimated PCD: 2025-01-01
Clinical trial
Study on Bioequivalence of Pramipexole Dihydrochloride Sustained Release TabletsStatus: Terminated, Estimated PCD: 2020-10-01
Clinical trial
Effect of Anticoagulant Drug Intervention on postoperativeMajor Adverse Limb Events and Major Adverse Cardiovascular Events in Patients With Peripheral Arterial DiseaseStatus: Recruiting, Estimated PCD: 2024-02-01
Clinical trial
Efficacy and Safety Analysis of Furmonertinib in Patients With Leptomeningeal Metastases Associated With EGFR Mutated NSCLC，Guiding by Cerebrospinal Fluid ctDNA DetectionStatus: , Estimated PCD: 2025-04-30
Clinical trial
A Prospective Open-label Single-arm Clinical Study of the Efficacy of Baricitinib for Idiopathic Granulomatous Mastitis in a Single InstitutionStatus: Recruiting, Estimated PCD: 2025-10-31
Clinical trial
A Prospective, National, Multi-centric, Non-interventional Study of First Line Osimertinib in Chinese Patients With Locally Advanced/Metastatic，EGFR Mutation-positive NSCLC in Real World SettingStatus: Active (not recruiting), Estimated PCD: 2022-04-26
Clinical trial
A Phase II Study of the Safety and Efficacy of Mitoxantrone Hydrochloride Liposome Injection, Cytarabine and Venetoclax in Patients With Relapsed/Refractory AMLStatus: Recruiting, Estimated PCD: 2025-06-01
Clinical trial
Azacitidine in Combination With Venetoclax Treatment for Prevention of Relapse in MRD Positive Post Allogeneic Hematopoietic Stem Cell Transplantation Acute Myelogenous Leukemia/ Myelodysplastic Syndrome PatientsStatus: Recruiting, Estimated PCD: 2024-03-19
Clinical trial
The Efficacy and Safety of TACE Combined With Tilelizumab and Sorafenib in Treating BCLC Stage C HCC Patients: a Single-center, Single-arm, Prospective Clinical StudyStatus: Recruiting, Estimated PCD: 2023-08-30
Clinical trial
An Open, Multi-center, Randomized Trial Comparing Haploidentical HSCTs From Young Non-first-degree and Older First-degree Donors in Hematological MalignanciesStatus: Recruiting, Estimated PCD: 2025-09-01
Clinical trial
A Phase I Study of Dose Escalation and Dose Expansion To Evaluate the Safety、Tolerability、Pharmacokinetics and Efficacy of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumor.Status: Recruiting, Estimated PCD: 2023-03-01
Clinical trial
Phase II Open-label, Multicentre, Exploratory Trial of Neoadjuvant Dalpiciclib in Combination With Exemestane and Trastuzumab Plus Pyrotinib in Early Triple Positive Breast CancerStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
The Effect of Dulaglutide as an Adjuvant Therapy on Cognitive Function in Bipolar Disorder Patients With ObesityStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
SBRT Sequential TACE Combined With Sorafenib Versus Sorafenib Alone in the Treatment of Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus：A Single-center Randomized Controlled StudyStatus: Recruiting, Estimated PCD: 2023-08-01
Clinical trial
Anticoagulant Plus Antiplatelet Therapy Following Iliac Vein StentingStatus: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
Effect and Mechanism of HD-tDCS Combined With Circadian Rhythm Remodeling on Consciousness Recovery in Patients With Chronic Disorder of ConsciousnessStatus: Recruiting, Estimated PCD: 2022-12-31
Abstract
Adjuvant nab-paclitaxel plus S-1 versus capecitabine plus oxaliplatin for patients with stage III gastric adenocarcinoma after D2 dissection: A multicenter, open-label, randomized phase 3 study.Org: Zhejiang Cancer Hospital, Chinese Academy of Sciences, University of Chinese Academy of Sciences Cancer Hospital, Hepato-Pancreato-Biliary & Gastric Medical Oncology, Cancer Hospital of the University of Chinese Academy of Sciences, Hangzhou, China, Institute of Cancer and Basic Medicine, Chinese Academy of Sciences,
Clinical trial
Director, Head of Anesthesiology and Critical Care, Principal Investigator, ProfessorStatus: Not yet recruiting, Estimated PCD: 2027-04-30
Clinical trial
Comparing the Efficacy and Safety of Autologous Hematopoietic Stem-cell Transplantation Versus Non Transplantation Regimen in Primary Multiple Myeloma Achieved MRD Negativity After Induction: A Multiple Center, Prospective Cohort StudyStatus: Recruiting, Estimated PCD: 2028-11-01
Clinical trial
Exploratory Study on the Efficacy and Safety of Methylene Blue in Treating Severe Septic Shock Patients: A Prospective, Randomized, Controlled TrialStatus: Not yet recruiting, Estimated PCD: 2026-06-20